RFP - supply of apomorphine hydrochloride, infusion pumps, dedicated pump syringes (if applicable) and associated consumables
PHARMAC invites proposals for the supply of apomorphine hydrochloride in New Zealand.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4pm NZT Friday 7 June 2019 - RFx ID 21020657.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
Decision to list patient warming and cooling medical devices supplied by Bard Australia PTY. Limited
We are pleased to announce the approval of a listing agreement with Bard Australia PTY. Limited for the supply of patient warming and cooling products to DHBs.
Proposal for changes to funded vaccines in the National Immunisation Schedule
We are proposing to make changes to the funding of vaccines in the National Immunisation Schedule following a Request for Proposals (RFP) for the supply of various vaccines.
Closes: 4pm on Friday, 31 May 2019.
Proposal to list medical devices supplied by Bunzl Outsourcing Services NZ Limited and B. Braun New Zealand Pty Limited
PHARMAC is seeking feedback on a proposal to list a range of continence products and urology products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through listing agreements with Bunzl Outsourcing Services NZ Limited and B. Braun New Zealand Pty Limited.
Closes: 4pm Wednesday, 29 May 2019.
Decision to list medical devices in the interventional radiology category supplied by Merit Medical Ltd
We are pleased to announce the approval of a listing agreement for medical devices with Merit Medical Ltd.
OIA Response: Antiepileptic medicines data
16 April 2019
Request dated 19 March 2019 under the Official Information Act 1982 (OIA) relating to females on antiepileptic medicines.
Decision to list a new brand of labetalol
PHARMAC has made a decision to fund a new brand of labetalol tablets (Presolol). This is to replace the currently funded brand of labetalol tablets (Hybloc), which is being discontinued by its supplier.
Proposal to list a range of orthopaedic implants and associated products supplied by Medartis New Zealand Ltd and Pioneer Medical Limited
PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through provisional agreements with Medartis New Zealand Ltd and Pioneer Medical Limited.
Closes: 4pm Tuesday, 28 May 2019.
OIA Response: Erlotinib and other medicines data
Request for information dated 4 February 2019 on erlotinib, obinutuzumab, pertuzumab, pirfenidone, rutixmab, trastuzumab, melanoma, multiple sclerosis and gefitinib.
Decision to list urology, ostomy and continence products
We are pleased to announce the approval of non-exclusive listing agreements with EBOS Group Limited, Ainscorp Pty Ltd and New Zealand Medical & Scientific Limited for the supply of urology, ostomy and continence products to DHBs.
RFP - supply of the levonorgestrel intrauterine system
PHARMAC invites proposals for the supply of the levonorgestrel intrauterine system in New Zealand.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4pm NZT Thursday 30 May 2019 - RFx ID 21000578.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
Decision to list medical devices in the interventional radiology category supplied by Obex Medical Ltd
We are pleased to announce the approval of a listing agreement for medical devices with Obex Medical Ltd.
OIA response: Sleeping medicines data
Request dated 04 March 2019 for information relating to sleeping pill medications.
Proposal to widen access to etanercept and award sole supply
We are proposing to make changes to the funding of etanercept, a biologic medicine used to reduce chronic inflammation and treat immune-mediated conditions such as arthritis and psoriasis, from 1 July 2019.
Closes: 5pm on Friday, 17 May 2019.
Decision to amend the distribution and access criteria for dasatinib (Sprycel)
PHARMAC has a made a decision to change the distribution arrangements and access criteria for the funding of dasatinib (Sprycel) tablets for chronic myeloid leukaemia (CML) and acute lymphoid leukaemia (ALL) from 1 June 2019.
Decision to list needles and syringes products supplied by Becton Dickinson Limited and Terumo Australia Pty Limited
We are pleased to announce the approval of two non-exclusive listing agreements with Becton Dickinson Limited and Terumo Australia Pty Limited for the supply of needle and syringe products to DHBs.
Decision to list continence products supplied by Downs Distributors Limited
We are pleased to announce the approval of a non-exclusive listing agreement with Downs Distributors Limited for the supply of continence products to DHBs.
Proposal to decline inactive applications
To help make our decision-making process clearer, we are seeking feedback on a proposal for PHARMAC to make decisions to decline funding applications as detailed below.
Closes: 5pm Tuesday, 21 May 2019.
April 2019 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018.
PHARMAC fully funding innovative improvements in haemophilia treatment
PHARMAC has today provided haemophilia patients fully funded access to new innovative treatment options which will make a major difference to their lives, PHARMAC Director of Operations Lisa Williams says.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Hospital News: News about getting the best value for what we spend on hospital pharmaceuticals.
Inpharmation: News about PHARMAC's activities and pharmaceutical-related issues.
Inpharmation in Hospitals: Hospital news about PHARMAC's activities and pharmaceutical-related issues.
Te Whaioranga ePānui: A PHARMAC newsletter for people with an interest in Māori health.
